Benznidazole Treatment: Time- and Dose-Dependence Varies with the Trypanosoma cruzi Strain

As the development of new drugs for Chagas disease is not a priority due to its neglected disease status, an option for increasing treatment adherence is to explore alternative treatment regimens, which may decrease the incidence of side effects. Therefore, we evaluated the efficacy of different the...

Descripción completa

Detalles Bibliográficos
Autores principales: Fonseca, Kátia da Silva, Perin, Luísa, de Paiva, Nívia Carolina Nogueira, da Silva, Beatriz Cristiane, Duarte, Thays Helena Chaves, Marques, Flávia de Souza, Costa, Guilherme de Paula, Molina, Israel, Correa-Oliveira, Rodrigo, Vieira, Paula Melo de Abreu, Carneiro, Cláudia Martins
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229751/
https://www.ncbi.nlm.nih.gov/pubmed/34207764
http://dx.doi.org/10.3390/pathogens10060729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229751/
https://www.ncbi.nlm.nih.gov/pubmed/34207764
http://dx.doi.org/10.3390/pathogens10060729

Ejemplares similares